Recombinant E.coli R70M Protein，His

The R70M recombinant protein has emerged as a significant focus of research due to its potential implications in various biomedical applications, particularly in the fields of enzyme technology and therapeutic development. This protein variant is characterized by a mutation at the 70th residue, where arginine is replaced by methionine (R70M), which may alter its functional properties and stability compared to the wild-type counterpart. Studies have indicated that such modifications can enhance the protein’s catalytic efficiency or alter its interaction with substrates, making it a valuable subject for protein engineering. Furthermore, understanding the structural and functional consequences of the R70M mutation can provide insights into disease mechanisms, particularly in conditions where enzyme dysfunction is implicated. The exploration of R70M also contributes to the broader field of synthetic biology, where engineered proteins can be designed for specific industrial processes or therapeutic applications. Researchers are actively investigating its properties through a combination of experimental and computational approaches, aiming to elucidate the relationship between its structure and function. This research avenue not only enhances our fundamental understanding of protein behavior but also opens up possibilities for innovative solutions to pressing medical and industrial challenges, positioning R70M as a promising candidate for future studies in protein biochemistry and biotechnology.